Medadvisor Share Price and Company Fundamentals



Price
$0.31
Change
0.005 (1.639%)
52 week
0.23 - 0.458357

Last traded: Last Friday at 5:45 AM

MedAdvisor Limited, together with its subsidiaries, develops and delivers software for personal medication management in Australia, the United States, the United Kingdom, and Asia. It develops and deploys the MedAdvisor, a medication and adherence platform that supports and empowers individuals and carers to manage all aspects of prescription medication using mobile and web apps. MedAdvisor Limited was incorporated in 2010 and is headquartered in Camberwell, Australia.

Key Metrics

PE ratio

-

PB ratio

2.42

Dividend yield

Beta

0.10

Market cap

$117M

Enterprise value

$119.39M

Company profile

Primary activitiesE-healthcare software developer
Industry / SectorHealth Information Services / Healthcare
Websitehttp://www.medadvisor.com.au
Mailing address971 Burke Road Level 2 Camberwell VIC 3124 Australia
Phone / Fax61 3 9095 3036 / 61 3 9882 3317
Share registryCOMPUTERSHARE INVESTOR SERVICES PTY LIMITED

Dividends

Medadvisor does not pay dividends.

Company Executives

As of Sep 2021, following are the company executives and directors listed on Medadvisor.

NameTitleAgeTotal Pay
Mr. Robert Read BComm(Mgt), BA(Psych), GAICDMD, CEO & Exec. Director313.12k
Mr. Joshua Swinnerton MEI, GradCert Eng., BE, BCS(Hons).Founder, Chief Product Officer & Exec. Director282.7k
Mr. Simon GloverChief Financial Officer216.94k
Mr. Craig SchnurigerInterim Chief Technology Officer
Ms. Naomi LawrieCompany Sec. & Gen. Counsel
Jennifer DuraisingamCorp. Communications Mang.
Ms. Ruba El-AfifiExec. Gen. Mang. of People & Culture
Mr. Jamal ButtHead of Commercial
Mr. Keith KiarsisPres & CEO of the US business
Mr. Steve WattChief Revenue Officer

Profitability and management effectiveness

Profit margin

-35.98%

Operating margin

-43.44%

Return on assets

-20.60%

Return on equity

-43.64%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Medadvisor is 117M and its enterprise value is 119.39M. The enterprise value to revenue ratio of MDR is 3.08.

The MDR's stocks Beta value is 0.10 making it 90% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Medadvisor (MDR)

Medadvisor (ASX:MDR) Frequently Asked Questions

1. What is Medadvisor's Stock Symbol?

Medadvisor trades on ASX under the ticker symbol "MDR".

2. What is Medadvisor's stock price today?

One share of MDR stock can currently be purchased for approximately $0.31.

3. How can I contact Medadvisor?

Medadvisor's mailing address is 971 Burke Road Level 2 Camberwell VIC 3124 Australia. The company can be reached via phone at 61 3 9095 3036.

4. What is Medadvisor's official website?

The official website of Medadvisor is http://www.medadvisor.com.au.

5. Which share registry manages Medadvisor's stock?

Medadvisor's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY LIMITED.